Document Detail

Risk factors of breast cancer-related lymphedema.
MedLine Citation:
PMID:  23772716     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Secondary lymphedema is one of the major important long-term complications of breast cancer treatment. The aim of this study is to determine patient- and treatment-related risk factors of lymphedema in breast cancer patients.
PATIENTS AND METHODS: Patients, who had been operated on for primary breast cancer at Akdeniz University Hospital and followed regularly between August 1984 and December 2009 were included in the study. In order to evaluate the arm swelling objectively, measurements were performed with a flexible tape measure for both arms, and limb volume was calculated using a truncated cone volume formula. Participants, whose volume difference between the two arms was ≥ 5%, were considered as lymphedema-positive patients. The SPSS program (SPSS inc. Chicago, IL) was used for statistical analysis.
RESULTS: The mean age of 455 patients was 50.6 years and the median follow-up time was 53 months. Lymphedema was found in 124 (27%) patients. Most of the patients with a history of postoperative wound infection (52%) and lymphangitis (57%) had lymphedema (p=0.003 and p=0.002, respectively). Addition of radiation therapy increased lymphedema risk 1.83 times (p=0.007). The mean duration of the axillary drainage and number of the removed lymph nodes were 7.8 days and 19, respectively. The rate of lymphedema in patients with early stage breast cancer was less than patients with advanced breast cancer (24% and 35.3%, respectively, p=0.018). Most of the patients (92%) with lymphedema had a high body mass index (BMI ≥ 25 kg/m²), and obesity was another important factor for lymphedema (p<0.001).
CONCLUSIONS: The most important treatment and patient-related risk factors for breast cancer-related lymphedema were obesity (≥ 25 kg/m²), axillary lymph node dissection, postoperative radiotherapy, wound infection, history of lymphangitis, and duration of axillary drainage. Elimination or prevention of these risk factors may reduce the incidence of lymphedema.
Saadet Ugur; Cumhur Arıcı; Muhittin Yaprak; Ayhan Mescı; Gulbin Ayse Arıcı; Kemal Dolay; Vahit Ozmen
Related Documents :
16237766 - Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas.
24454466 - Invasive breast carcinoma arising in microglandular adenosis: two case reports.
15893416 - The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression.
2989146 - Nuclear morphometry of epitheliosis and intraduct carcinoma of the breast.
1306326 - Tumor localization and biodistribution with radiolabeled monoclonal antibody against pa...
22986226 - Development of a new optical device and its feasibility in prostate cancer detection.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Lymphatic research and biology     Volume:  11     ISSN:  1557-8585     ISO Abbreviation:  Lymphat Res Biol     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-06-18     Completed Date:  2014-01-15     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  101163587     Medline TA:  Lymphat Res Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  72-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Breast Neoplasms / complications,  surgery*
Lymphedema / complications*
Middle Aged
Postoperative Complications
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Factors affecting the preoperative and postoperative extracellular fluid in the arm on the side of b...
Next Document:  An experimental lymphoscintigraphy study in an acute unilateral deep venous thrombosis model.